Alpha Centric Advisors LLC Dynavax Technologies Corp Transaction History
Alpha Centric Advisors LLC
- $118 Million
- Q3 2024
A detailed history of Alpha Centric Advisors LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 201,500 shares of DVAX stock, worth $2.56 Million. This represents 1.9% of its overall portfolio holdings.
Number of Shares
201,500
Previous 130,000
55.0%
Holding current value
$2.56 Million
Previous $1.46 Million
53.8%
% of portfolio
1.9%
Previous 1.2%
Shares
11 transactions
Others Institutions Holding DVAX
# of Institutions
275Shares Held
130MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$279 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$159 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$117 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$106 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$97.8 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.61B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...